Health Care • Biotechnology: Pharmaceutical Preparations
$60.49 ▲ +0.28
(+0.47%)
MKT CAP: $8.54B • VOL: 1.28M
52W L $37 52W H $95
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$51
MEDIAN
$68
MEAN
$69
HIGH
$82
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE ARWR TAPE
ARWR // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $73.19 | $69.56 | 2025-02-14 | $55.05 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $76.22 | $71.38 | 2025-02-06 | $56.86 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $68.96 | $66.54 | 2025-01-29 | $58.07 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $61.70 | — | 2025-01-17 | $59.28 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $53.23 | $57.47 | 2025-01-09 | $53.84 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $71.98 | $62.91 | 2024-12-18 | $52.63 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $58.68 | $61.09 | 2024-12-04 | $56.26 | -4.3% | 48% | C |